Scholarlink

Background <p>Colorectal adenocarcinoma (COAD) accounts for approximately 90% of colorectal cancer (CRC) cases and is the most common histological subtype of CRC. COAD, a malignancy associated with high morbidity and mortality, remains a topic of debate, with its underlying molecular mechanisms requiring further investigation.</p> Methods <p>Differential analysis and survival analysis were used to evaluate IGF2BP3 expression and prognosis. CCK8, colony formation, and the impact of IGF2BP3 on tumor malignancy were analyzed in transwell apples. GEO data were used to screen potential substrates modified by IGF2BP3. Western blotting, RT-qPCR, and RIP-qPCR were used to validate the predictions. Animal models were constructed to validate the tumor-promoting effects of IGF2BP3.</p> Results <p>IGF2BP3 is highly expressed in COAD and correlates with poor patient prognosis. IGF2BP3 activates the JAK2/STAT3 signaling pathway by recognizing m6A-modified IL6ST mRNA. STAT3 transcriptionally regulates IGF2BP3. Importantly, IGF2BP3 enhances the malignant phenotype of COAD both in vivo and in vitro.</p> Conclusions <p>In this study, we found IGF2BP3 promotes tumor progression in an m6a manner. Mechanistically, IGF2BP3 recognizes and stabilizes IL6ST, activating the JAK2/STAT3 pathway. In turn, STAT3 transcriptionally activates IGF2BP3, forming an IGF2BP3-STAT3 positive feedback loop that promotes tumorigenesis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Positive feedback loop of IGF2BP3/IL6ST/STAT3 facilitates malignant progression in colorectal cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月25日

查看全文
  • Peng Liu,
  • Xueming Zhou

摘要

Background

Colorectal adenocarcinoma (COAD) accounts for approximately 90% of colorectal cancer (CRC) cases and is the most common histological subtype of CRC. COAD, a malignancy associated with high morbidity and mortality, remains a topic of debate, with its underlying molecular mechanisms requiring further investigation.

Methods

Differential analysis and survival analysis were used to evaluate IGF2BP3 expression and prognosis. CCK8, colony formation, and the impact of IGF2BP3 on tumor malignancy were analyzed in transwell apples. GEO data were used to screen potential substrates modified by IGF2BP3. Western blotting, RT-qPCR, and RIP-qPCR were used to validate the predictions. Animal models were constructed to validate the tumor-promoting effects of IGF2BP3.

Results

IGF2BP3 is highly expressed in COAD and correlates with poor patient prognosis. IGF2BP3 activates the JAK2/STAT3 signaling pathway by recognizing m6A-modified IL6ST mRNA. STAT3 transcriptionally regulates IGF2BP3. Importantly, IGF2BP3 enhances the malignant phenotype of COAD both in vivo and in vitro.

Conclusions

In this study, we found IGF2BP3 promotes tumor progression in an m6a manner. Mechanistically, IGF2BP3 recognizes and stabilizes IL6ST, activating the JAK2/STAT3 pathway. In turn, STAT3 transcriptionally activates IGF2BP3, forming an IGF2BP3-STAT3 positive feedback loop that promotes tumorigenesis.